Cumulative probability of prostate cancer was greater at all ages up to 76 years, for men with vertex versus no androgenetic alopecia at age of 40 years. At age of 76 years, the estimated probabilities converged to 0.15. Vertex androgenetic alopecia at 40 years was also associated with younger...
Martinez-Pin藴eiro L, Garcia Mediero P, Gonzalez Gancedo JM, Tabernero A, et al: Probability of prosta- te cancer as a function of the percentage of free prostate- specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4-10 ng/ml. ...
Figure 4.—Probability of cancer by percentage of free prostate-specific antigen (PSA) and patient age for patients with PSA levels between 4.0 and 10.0 ng/mL. Table 1.—Results of Prostate Cancer Detection Testing With PSA and DRE* Table 2.—Current Clinical Practice and Proportion of Men ...
The probability that a cancer will be of high grade at diagnosis increases with the lead time. Our findings provide evidence of grade progression, whereby a prostate followed over time would exhibit transitions from benign to low-grade to high-grade prostate cancer. 展开 关键词: Lead-time ...
The probability of prostate cancer in each segment on MR images was recorded with a five-point scale. Areas under the receiver operating characteristic curve (AUCs) were compared by using the Z test; sensitivity and specificity were determined with the Z test after adjusting for data clustering....
Johnny’s PSA was 7,292 on 24 September 2022 (don’t be mistaken, it was 7.2 thousand plus not 7.2). To be “free or cured” of prostate cancer the PSA needs to come down to 6.50 ( yes, 6 point 5 for age 70 and above). When can that happen? Or can that ever happen?
Pre- dicting the probability of significant prostate cancer in Japanese men with serum prostate-specific antigen less than 10 ng/mL: development of a novel pre-biopsy nomogram. Int J Urol 2010;17:274-279.S. Yamamoto, "Editorial comment to predicting the proba- bility significant prostate ...
Selection of treatment for a patient with prostate cancer is often based on age and life expectancy. However, life expectancy estimates are often calculated solely on the basis of chronological age, overlooking comorbid conditions and their severity, whi
Table 1 Crude and adjusted probability of prostate cancer specific and all cause mortality. Hazard Ratios (HR) are adjusted for age, race, marital status, PSA, Gleason score, Stage, AJCC staging (TNM), therapy, bone metastasis. The model for prostate cancer specific mortality treats non-prostat...
This survival decline with age was statistically significant (P < .001) and indicates that the ageassociated risk of clinically significant localized prostate cancer, as identified by Huynh-Le et al, might translate into worse 5-year survival. However, the 5-year survival of all men must be ...